SQI Partners With McMaster University To Develop Testing Tech

SQI Diagnostics (TSXV:SQD; OTCQX:SQIDF) announced a technology development partnership and licensing agreement with the McMaster University Department of Engineering to develop chip technology for use in multi-array disease testing.
As quoted in the press release:

SQI’s existing proprietary technology enables global pharmaceutical and diagnostic testing companies to perform highly complex multiplex tests much faster, more accurately and at a lower cost.
The market for these tests is global, measured in the hundreds of millions of dollars, and growing. And an even larger market awaits in testing for diseases at the point of care such as hospitals, ER units and medical offices, using rapid, portable diagnostic devices that can provide results in minutes. Early in 2017 SQI approached Dr. Ishwar Puri’s team of the McMaster University Department of Engineering who are pioneers in creating novel detection technologies.
Their initial work has now advanced to the stage where SQI and McMaster are partnering to further develop the instant chip technology and detection devices that will enable a wide-array of multi-result tests to be offered directly to health care professionals and patients in clinical settings worldwide.

Click here to read the full press release.

Source: www.newswire.ca